Net Cash Provided by (Used in) Operating Activities of Yubo International Biotech Ltd from 28 Feb 2011 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
Yubo International Biotech Ltd quarterly and annual Net Cash Provided by (Used in) Operating Activities in USD history and change rate from 28 Feb 2011 to 31 Mar 2025.
  • Yubo International Biotech Ltd Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Mar 2025 was $392,045, a 19% decline year-over-year.
  • Yubo International Biotech Ltd annual Net Cash Provided by (Used in) Operating Activities for 2024 was $1,337,729, a 81% decline from 2023.
  • Yubo International Biotech Ltd annual Net Cash Provided by (Used in) Operating Activities for 2023 was $738,971, a 23% decline from 2022.
  • Yubo International Biotech Ltd annual Net Cash Provided by (Used in) Operating Activities for 2022 was $600,953, a 41% increase from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)

Yubo International Biotech Ltd Quarterly Net Cash Provided by (Used in) Operating Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $392,045 -$61,443 -19% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q1 2024 $330,602 -$297,933 -912% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q1 2023 $32,669 -$83,639 -164% 01 Jan 2023 31 Mar 2023 10-Q 20 May 2024 2024 Q1
Q1 2022 $50,970 +$1,053,548 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q1 2021 $1,002,578 -$510,989 -104% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q2 2020 $4,000 +$4,000 +50% 01 Mar 2020 31 May 2020 10-Q 20 Jul 2020 2021 Q1
Q1 2020 $491,589 01 Jan 2020 31 Mar 2020 10-Q 24 May 2021 2021 Q1
Q2 2019 $8,000 +$3,000 +27% 01 Mar 2019 31 May 2019 10-Q 20 Jul 2020 2021 Q1
Q2 2018 $11,000 +$11,000 +50% 01 Mar 2018 31 May 2018 10-Q 11 Jul 2019 2020 Q1
Q2 2017 $22,000 -$14,000 -175% 01 Mar 2017 31 May 2017 10-Q 16 Jul 2018 2019 Q1
Q2 2016 $8,000 +$6,000 +43% 01 Mar 2016 31 May 2016 10-Q 14 Jul 2017 2018 Q1
Q2 2015 $14,000 +$12,000 +46% 01 Mar 2015 31 May 2015 10-Q 12 Jul 2016 2017 Q1
Q2 2014 $26,000 -$23,000 -767% 01 Mar 2014 31 May 2014 10-Q 09 Jul 2015 2016 Q1
Q2 2013 $3,000 $0 0% 01 Mar 2013 31 May 2013 10-Q 23 Jun 2014 2015 Q1
Q2 2012 $3,000 +$1,000 +25% 01 Mar 2012 31 May 2012 10-Q 15 Jul 2013 2013 Q1
Q2 2011 $4,000 01 Mar 2011 31 May 2011 10-Q 12 Jul 2012 2012 Q1

Yubo International Biotech Ltd Annual Net Cash Provided by (Used in) Operating Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $1,337,729 -$598,758 -81% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
2023 $738,971 -$138,018 -23% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2022 $600,953 +$419,908 +41% 01 Jan 2022 31 Dec 2022 10-K 12 Apr 2024 2023 FY
2021 $1,020,861 -$1,121,968 -1110% 01 Jan 2021 31 Dec 2021 10-K 14 Apr 2023 2022 FY
2020 $101,107 +$123,107 01 Jan 2020 31 Dec 2020 10-K 15 Apr 2022 2021 FY
2019 $22,000 +$10,000 +31% 01 Mar 2019 29 Feb 2020 10-KT 23 Apr 2021 2020 FY
2018 $32,000 +$23,000 +42% 01 Mar 2018 28 Feb 2019 10-KT 23 Apr 2021 2020 FY
2017 $55,000 $0 0% 01 Mar 2017 28 Feb 2018 10-K 12 Jun 2019 2019 FY
2016 $55,000 +$1,000 +1.8% 01 Mar 2016 28 Feb 2017 10-K 13 Jun 2018 2018 FY
2015 $56,000 +$7,000 +11% 01 Mar 2015 29 Feb 2016 10-K 14 Jun 2017 2017 FY
2014 $63,000 -$17,000 -37% 01 Mar 2014 28 Feb 2015 10-K 10 Jun 2016 2016 FY
2013 $46,000 -$8,000 -21% 01 Mar 2013 28 Feb 2014 10-K 15 Jun 2015 2015 FY
2012 $38,000 +$5,000 +12% 01 Mar 2012 28 Feb 2013 10-K 06 Jun 2014 2014 FY
2011 $43,000 +$6,000 +12% 01 Mar 2011 29 Feb 2012 10-K 12 Jun 2013 2012 FY
2010 $49,000 01 Mar 2010 28 Feb 2011 10-K 11 Jun 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.